Women in EB

  • R. Alta Charo

    R. Alta Charo (Harvard, BA biology 1979; Columbia, JD law 1982) is a 2019-2020 Berggruen Fellow at CASBS, and the Warren P. Knowles Professor of Law and Bioethics at the University of Wisconsin, writing on medical ethics and biotechnology regulatory policy. In government, she served as a legal analyst for the former congressional Office of Technology Assessment, policy analyst for the US Agency for International Development and senior policy advisor in the FDA’s Office of the Commissioner. She was a member of the National Bioethics Advisory Commission under President Clinton, and the transition team for President Obama. Charo is a member of the National Academy of Medicine, and co-chaired its committee on Guidelines for Embryonic Stem Cell Research and its 2017 committee on Human Genome Editing: Science, Ethics and Governance. At present, she is a member of the World Health Organization’s committee on global governance of genome editing, of the Nuclear Threat Initiative’s Biosecurity Innovation and Risk Reduction project, and of the steering committee of the International Society for Stem Cell Research’s effort to revise and expand its guidelines for ethical research, including research on chimeras and organoids.

  • Gigi Gronvall

    Gigi Gronvall is a Senior Scholar at the Johns Hopkins Center for Health Security and an Associate Professor in the Department of Environmental Health and Engineering at the Johns Hopkins Bloomberg School of Public Health. Dr. Gronvall is the author of the book Synthetic Biology: Safety, Security, and Promise, published in fall 2016 (Health Security Press) and Preparing for Bioterrorism: The Alfred P. Sloan Foundation’s Leadership in Biosecurity. (2013) She is a member of the Novel and Exceptional Technology and Research Advisory Committee (NExTRAC) which provides recommendations to the NIH Director and is a public forum for the discussion of the scientific, safety, and ethical issues associated with emerging biotechnologies. Dr. Gronvall is a member of the Threat Reduction Advisory Committee (TRAC), which provides the Secretary of Defense with independent advice and recommendations on reducing the risk to the United States, its military forces, and its allies and partners posed by nuclear, biological, chemical, and conventional threats. She served as the Science Advisor for the Commission on the Prevention of Weapons of Mass Destruction Proliferation and Terrorism from April 2009 until February 2010. Dr. Gronvall is an Associate Editor of the journal Health Security, and is a Life Member of the Council on Foreign Relations. She was a National Research Council Postdoctoral Associate at the US Army Medical Research Institute of Infectious Diseases (USAMRIID) in Fort Detrick, Maryland. Dr. Gronvall received a BS in biology from Indiana University, Bloomington, worked as a protein chemist at the Memorial Sloan-Kettering Cancer Center and received a PhD from Johns Hopkins University for work on T-cell receptor/MHC I interactions.

  • Deepti Tanjore

    At ABPDU, our passion for bio-innovation drives us. Every day. Whether we’re evaluating biomass, experimenting with microorganisms, optimizing new processes, or performing assays and analyses, our end goal never changes. Simply put, we want to enable you to successfully take your bio-innovation to market.

    We’ve been operational since 2012, collaborating with researchers in the bio-products industry, the National Labs, and academia to optimize and scale technologies to enable the commercialization of bio-based chemicals, materials, and fuels.

  • Mary Dunlop

    control theory, stochastic gene expression, gene regulatory networks, feedback

  • Anne Meyer

    The Meyer lab performs research targeted at re-engineering bacteria to synthesize bio-inspired materials with improved properties. This approach has the potential to replace traditional chemical approaches that require extreme environmental conditions, expensive equipment, and the generation of hazardous waste. As a first step we have targeted bacterial production of patterned artificial nacre, a biomineralized material lining seashells that combines high mechanical strength with high fracture toughness. Combination of our biological materials-producing systems with our newly developed 3D bacterial printers will allow the rapid and straight-forward production of spatially structured biomaterials.

  • Kathleen Vogel

    policy, biosecurity, defense applications

  • Arti Rai

    intellectual property, policy, biotechnology, pharmaceuticals

  • Jackie Quinn

    bioengineering, design languages, computer aided design, computational tools

  • Kristala Prather

    metabolic engineering, metabolic flux, bioprocess engineering

  • Caroline Peres

    microbial physiology, fermentation engineering, metabolic engineering, molecular biology

  • Pamela Peralta-Yahya

    metabolic engineering, chemical synthesis, biosensors, biofuels, alkaloids, microbial synthesis

  • Joelle Pelletier

    molecular modeling, enzymology, protein engineering, directed evolution

  • Marilene Pavan Rodrigues

    biotechnology, synthetic biology, computational biology

  • Grace Paradise

    flavorings, natural products, chemistry, organic chemistry

  • Megan Palmer

    biosafety, biosecurity, leadership, science policy

  • Irene Otero-Muras

    computational tools for synthetic biology, automated biorcircuit design, computational systems biology, biochemical networks, optimization

  • Anne Osbourn

    plant synthetic biology, metabolic pathway engineering

  • Sarah Munro

    synthetic biology, biomedical measurement science

  • June Medford

    plant synthetic biology, synthetic biology, signal transduction, biosensors, biofuels

  • Back to top ⇑